Prot# XP052: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients with Restless Legs Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date3/13/06 → 11/22/11

Funding

  • XenoPort, Inc. (XP052)